INTRODUCTION: This study aimed to assess the association between fasting serum C-peptide levels and the presence of impaired awareness of hypoglycemia (IAH) in people with type 1 diabetes. RESEARCH DESIGN AND METHODS: We performed a cross-sectional study among 509 individuals with type 1 diabetes (diabetes duration 5-65 years). Extensive clinical data and fasting serum C-peptide concentrations were collected and related to the presence or absence of IAH, which was evaluated using the validated Dutch version of the Clarke questionnaire. A multivariable logistic regression model was constructed to investigate the association of C-peptide and other clinical variables with IAH. RESULTS: In 129 (25%) individuals, residual C-peptide secretion was...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
Aims: This study aims to evaluate the stability of C-peptide over time and to compare fasting C-pept...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...
INTRODUCTION: This study aimed to assess the association between fasting serum C-peptide levels and ...
Context: High-residual C-peptide in longer-duration type 1 diabetes (T1D) is associated with fewer h...
OBJECTIVE: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
OBJECTIVE — A protective effect of residual -cell function on microvascular complications of type 1 ...
Background: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency...
Most people with Type 1 diabetes have low levels of persistent endogenous insulin production. The Di...
Context High-residual C-peptide in longer-duration type 1 diabetes (T1D) is associated with fewer...
Background and aims: Previous studies suggested that long-term perseverance of beta-cell function in...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
Aims: This study aims to evaluate the stability of C-peptide over time and to compare fasting C-pept...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...
INTRODUCTION: This study aimed to assess the association between fasting serum C-peptide levels and ...
Context: High-residual C-peptide in longer-duration type 1 diabetes (T1D) is associated with fewer h...
OBJECTIVE: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
OBJECTIVE — A protective effect of residual -cell function on microvascular complications of type 1 ...
Background: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency...
Most people with Type 1 diabetes have low levels of persistent endogenous insulin production. The Di...
Context High-residual C-peptide in longer-duration type 1 diabetes (T1D) is associated with fewer...
Background and aims: Previous studies suggested that long-term perseverance of beta-cell function in...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
Aims: This study aims to evaluate the stability of C-peptide over time and to compare fasting C-pept...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...